Goldberg, M. R., Lee, Y., Vyas, K. P., Slaughter, D. E., Panebianco, D., Ermlich, S. J., . . . Olah, T. V. (2000). Rizatriptan, a novel 5-HT1B/1D agonist for migraine: Single- and multiple-dose tolerability and pharmacokinetics in healthy subjects. Journal of clinical pharmacology, 40(1), 74. https://doi.org/10.1177/009127000004000110
Citace podle Chicago (17th ed.)Goldberg, M R., et al. "Rizatriptan, a Novel 5-HT1B/1D Agonist for Migraine: Single- and Multiple-dose Tolerability and Pharmacokinetics in Healthy Subjects." Journal of Clinical Pharmacology 40, no. 1 (2000): 74. https://doi.org/10.1177/009127000004000110.
Citace podle MLA (9th ed.)Goldberg, M R., et al. "Rizatriptan, a Novel 5-HT1B/1D Agonist for Migraine: Single- and Multiple-dose Tolerability and Pharmacokinetics in Healthy Subjects." Journal of Clinical Pharmacology, vol. 40, no. 1, 2000, p. 74, https://doi.org/10.1177/009127000004000110.